0000899243-20-012077.txt : 20200505 0000899243-20-012077.hdr.sgml : 20200505 20200505171658 ACCESSION NUMBER: 0000899243-20-012077 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200428 FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gullotta Tina CENTRAL INDEX KEY: 0001811378 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 20850045 MAIL ADDRESS: STREET 1: SUNESIS PHARMACEUTICALS,INC STREET 2: 395 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-04-28 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001811378 Gullotta Tina SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 VP, Finance Common Stock 14500 D Stock Option (Right to Buy) 2.18 2028-08-31 Common Stock 40000 D Stock Option (Right to Buy) 0.4157 2028-12-31 Common Stock 8611 D Stock Option (Right to Buy) 1.215 2029-03-29 Common Stock 10000 D Stock Option (Right to Buy) 0.4149 2030-03-31 Common Stock 70000 D One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of August 31, 2018. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of December 31, 2018. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 29, 2019. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months /s/ Tina Gullotta 2020-05-05